1. Home
  2. ALIT vs KMDA Comparison

ALIT vs KMDA Comparison

Compare ALIT & KMDA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Alight Inc.

ALIT

Alight Inc.

HOLD

Current Price

$0.75

Market Cap

496.4M

ML Signal

HOLD

Logo Kamada Ltd.

KMDA

Kamada Ltd.

HOLD

Current Price

$7.17

Market Cap

460.3M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
ALIT
KMDA
Founded
2017
1990
Country
United States
Israel
Employees
N/A
N/A
Industry
Business Services
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
496.4M
460.3M
IPO Year
2020
2013

Fundamental Metrics

Financial Performance
Metric
ALIT
KMDA
Price
$0.75
$7.17
Analyst Decision
Buy
Strong Buy
Analyst Count
6
2
Target Price
$3.75
$14.00
AVG Volume (30 Days)
25.6M
54.0K
Earning Date
05-05-2026
05-13-2026
Dividend Yield
21.33%
3.08%
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$2,262,000,000.00
N/A
Revenue This Year
N/A
$13.94
Revenue Next Year
$0.14
$9.84
P/E Ratio
N/A
$24.59
Revenue Growth
N/A
N/A
52 Week Low
$0.48
$6.50
52 Week High
$6.03
$9.35

Technical Indicators

Market Signals
Indicator
ALIT
KMDA
Relative Strength Index (RSI) 43.37 28.92
Support Level $0.67 $6.87
Resistance Level $1.01 $7.41
Average True Range (ATR) 0.09 0.14
MACD -0.02 -0.06
Stochastic Oscillator 6.43 0.56

Price Performance

Historical Comparison
ALIT
KMDA

About ALIT Alight Inc.

Alight Inc is a technology-enabled services company delivering human capital management solutions to many complex organizations. This includes the implementation and administration of employee benefits (e.g., health, wealth, and leave benefits) solutions, which currently operate under one reportable segment, Employer Solutions. The Employer Solutions segment is driven by the Alight Worklife platform, and includes integrated benefits administration, healthcare navigation, financial well-being, leave of absence management, and retiree healthcare. Geographically, the company generates the majority of its revenue from the United States.

About KMDA Kamada Ltd.

Kamada Ltd is a drug-focused, plasma-derived protein therapeutics company. It is involved in the business of developing, producing, and marketing specialty therapeutics using protein purification proprietary technology. Its product portfolio consists of Glassia, Bramitob, Foster, Ixiaro, Factor-IX, and others. The company has two segments namely, the Proprietary Products segment and the Distribution segment. It derives the majority of its revenue from the Proprietary products segment. The firm categorizes its products in Lung Disease, Vaccines, Haemophilia, Immunoglobulins, Critical care, and Diagnostics.

Share on Social Networks: